• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing.在撒哈拉以南非洲地区提高儿童神经发育评估能力:实施标准化神经发育测试的质量保证模型。
Child Neuropsychol. 2019 May;25(4):466-481. doi: 10.1080/09297049.2018.1497588. Epub 2018 Aug 14.
2
Cross-cultural assessment of HIV-associated cognitive impairment using the Kaufman assessment battery for children: a systematic review.使用考夫曼儿童评估量表对与HIV相关的认知障碍进行跨文化评估:一项系统综述。
J Int AIDS Soc. 2017 Jun 14;20(1):21412. doi: 10.7448/IAS.20.1.21412.
3
Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.在一项多中心抗逆转录病毒临床试验中,感染艾滋病毒的非洲儿童的神经心理学表现。
AIDS. 2018 Jan 14;32(2):189-204. doi: 10.1097/QAD.0000000000001683.
4
Piloting the adaptation of the Kaufman Assessment Battery for Children-2 edition (KABC-II) to assess school-age neurodevelopment in rural Zimbabwe.试行改编考夫曼儿童评估量表第二版(KABC-II)以评估津巴布韦农村地区学龄儿童的神经发育情况。
Wellcome Open Res. 2024 May 30;7:274. doi: 10.12688/wellcomeopenres.17902.2. eCollection 2022.
5
Neurocognitive testing in West African children 3-6 years of age: Challenges and implications for data analyses.西非 3-6 岁儿童的神经认知测试:数据分析的挑战及意义。
Brain Res Bull. 2019 Feb;145:129-135. doi: 10.1016/j.brainresbull.2018.04.001. Epub 2018 Apr 6.
6
Validity of Neuropsychological Testing in Young African Children Affected by HIV.受艾滋病毒影响的非洲幼儿神经心理测试的有效性
J Pediatr Infect Dis. 2018 Sep;13(3):185-201. doi: 10.1055/s-0038-1637020.
7
Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa.撒哈拉以南非洲地区感染 HIV 与未感染 HIV 的儿童的神经发育情况。
J Int AIDS Soc. 2023 Oct;26 Suppl 4(Suppl 4):e26159. doi: 10.1002/jia2.26159.
8
The Quality Assurance Project: introducing quality improvement to primary health care in less developed countries.质量保证项目:在欠发达国家的初级卫生保健中引入质量改进
Qual Assur Health Care. 1991;3(3):147-65. doi: 10.1093/intqhc/3.3.147.
9
A preliminary examination of the construct validity of the KABC-II in Ugandan children with a history of cerebral malaria.对有脑型疟疾病史的乌干达儿童进行考夫曼儿童评估成套测验第二版(KABC-II)结构效度的初步检验。
Afr Health Sci. 2009 Sep;9(3):186-92.
10
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus.非洲多中心 2 年随访研究:儿童期感染、暴露及未感染人类免疫缺陷病毒的学龄儿童的神经心理学表现。
Clin Infect Dis. 2020 Oct 23;71(7):e105-e114. doi: 10.1093/cid/ciz1088.

引用本文的文献

1
Neuronal Damage in Murine Experimental Cerebral Malaria, Implications for Neuronal Repair and Sequelae.小鼠实验性脑型疟疾中的神经元损伤,对神经元修复和后遗症的影响。
Cells. 2025 May 30;14(11):807. doi: 10.3390/cells14110807.
2
Predictors of trajectories of child neurodevelopment in the first 2 years of life in LMICs: A systematic review and meta-analysis protocol.低收入和中等收入国家儿童出生后头两年神经发育轨迹的预测因素:一项系统评价和荟萃分析方案
Res Sq. 2025 Apr 16:rs.3.rs-5285073. doi: 10.21203/rs.3.rs-5285073/v1.
3
Piloting the adaptation of the Kaufman Assessment Battery for Children-2 edition (KABC-II) to assess school-age neurodevelopment in rural Zimbabwe.试行改编考夫曼儿童评估量表第二版(KABC-II)以评估津巴布韦农村地区学龄儿童的神经发育情况。
Wellcome Open Res. 2024 May 30;7:274. doi: 10.12688/wellcomeopenres.17902.2. eCollection 2022.
4
Association of severe malaria with cognitive and behavioural outcomes in low- and middle-income countries: a meta-analysis and systematic review.中低收入国家重度疟疾与认知和行为结果的相关性:荟萃分析和系统评价。
Malar J. 2023 Aug 3;22(1):227. doi: 10.1186/s12936-023-04653-9.
5
The role of digital health in palliative care for people living with HIV in sub-Saharan Africa: A systematic review.数字健康在撒哈拉以南非洲地区艾滋病毒感染者姑息治疗中的作用:一项系统综述。
Digit Health. 2022 Nov 22;8:20552076221133707. doi: 10.1177/20552076221133707. eCollection 2022 Jan-Dec.
6
Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa.抗逆转录病毒药物的选择和严重疾病预示着非洲感染艾滋病毒儿童的神经心理预后较差。
Front Pediatr. 2022 Aug 3;10:899002. doi: 10.3389/fped.2022.899002. eCollection 2022.
7
Neurodevelopmental performance among pre-schoolers treated for severe anaemia at Lira Regional Referral Hospital, Uganda.乌干达利拉地区转诊医院接受重度贫血治疗的学龄前儿童的神经发育表现。
PLoS One. 2020 Nov 4;15(11):e0240694. doi: 10.1371/journal.pone.0240694. eCollection 2020.
8
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus.非洲多中心 2 年随访研究:儿童期感染、暴露及未感染人类免疫缺陷病毒的学龄儿童的神经心理学表现。
Clin Infect Dis. 2020 Oct 23;71(7):e105-e114. doi: 10.1093/cid/ciz1088.

本文引用的文献

1
Validity of Neuropsychological Testing in Young African Children Affected by HIV.受艾滋病毒影响的非洲幼儿神经心理测试的有效性
J Pediatr Infect Dis. 2018 Sep;13(3):185-201. doi: 10.1055/s-0038-1637020.
2
Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.在一项多中心抗逆转录病毒临床试验中,感染艾滋病毒的非洲儿童的神经心理学表现。
AIDS. 2018 Jan 14;32(2):189-204. doi: 10.1097/QAD.0000000000001683.
3
CNS Impact of Perinatal HIV Infection and Early Treatment: the Need for Behavioral Rehabilitative Interventions Along with Medical Treatment and Care.围产期HIV感染和早期治疗对中枢神经系统的影响:在药物治疗和护理之外进行行为康复干预的必要性。
Curr HIV/AIDS Rep. 2016 Dec;13(6):318-327. doi: 10.1007/s11904-016-0342-8.
4
Early childhood development coming of age: science through the life course.幼儿发展步入成年期:贯穿生命历程的科学
Lancet. 2017 Jan 7;389(10064):77-90. doi: 10.1016/S0140-6736(16)31389-7. Epub 2016 Oct 4.
5
[Formula: see text]Selecting measures for the neurodevelopmental assessment of children in low- and middle-income countries.[公式:见正文]为低收入和中等收入国家儿童选择神经发育评估措施。
Child Neuropsychol. 2017 Oct;23(7):761-802. doi: 10.1080/09297049.2016.1216536. Epub 2016 Sep 9.
6
Can we measure cognitive constructs consistently within and across cultures? Evidence from a test battery in Bangladesh, Ghana, and Tanzania.我们能否在不同文化内部和之间持续测量认知结构?来自孟加拉国、加纳和坦桑尼亚一项测试组合的证据。
Appl Neuropsychol Child. 2018 Jan-Mar;7(1):1-13. doi: 10.1080/21622965.2016.1206823. Epub 2016 Jul 27.
7
A Randomized Controlled Trial to Evaluate if Computerized Cognitive Rehabilitation Improves Neurocognition in Ugandan Children with HIV.一项评估计算机化认知康复是否能改善乌干达感染艾滋病毒儿童神经认知的随机对照试验。
AIDS Res Hum Retroviruses. 2016 Aug;32(8):743-55. doi: 10.1089/AID.2016.0026. Epub 2016 May 2.
8
HIV Encephalopathy: pediatric case series description and insights from the clinic coalface.人类免疫缺陷病毒相关性脑病:儿科病例系列描述及临床一线观察
AIDS Res Ther. 2015 Jan 17;12(1):2. doi: 10.1186/s12981-014-0042-7. eCollection 2015.
9
Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.暴露于HIV但未感染的儿童与未暴露于HIV的儿童的神经发育结局。
AIDS Care. 2014;26(11):1327-35. doi: 10.1080/09540121.2014.920949. Epub 2014 May 30.
10
A year-long caregiver training program improves cognition in preschool Ugandan children with human immunodeficiency virus.一项为期一年的照料者培训计划可改善感染人类免疫缺陷病毒的学龄前乌干达儿童的认知能力。
J Pediatr. 2013 Nov;163(5):1409-16.e1-5. doi: 10.1016/j.jpeds.2013.06.055. Epub 2013 Aug 16.

在撒哈拉以南非洲地区提高儿童神经发育评估能力:实施标准化神经发育测试的质量保证模型。

Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing.

机构信息

a Psychiatry Department , Michigan State University , East Lansing , USA.

b Makerere University-Johns Hopkins University Research Collaboration (MU-JHU) , Kampala , Uganda.

出版信息

Child Neuropsychol. 2019 May;25(4):466-481. doi: 10.1080/09297049.2018.1497588. Epub 2018 Aug 14.

DOI:10.1080/09297049.2018.1497588
PMID:30105934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6375801/
Abstract

Compromised neurodevelopment (ND) among infants and children is prevalent in sub-Saharan Africa. Standardized testing of ND is frequently prohibitive in these contexts, as tests require skilled staff for their application. In this paper, we present a quality assurance (QA) model (QualiND) for standardized ND testing, discussing findings and implications from our experience applying the Kaufman Assessment Battery for Children second edition (KABC-II). The QualiND model was implemented within IMPAACT P1104s study, a multisite, prospective study including 615 children affected by HIV. From 2014 to 2016, the QualiND managed 18 testers across 6 sites located in 4 African countries applying the KABC-II in 9 local languages. The QualiND is a multilevel, video-assisted iterative model incorporating remote evaluation, feedback, and supervision roles. Using an ad hoc rubric, videos of test application were evaluated by experienced staff in a centralized QA center. At each study site, testers and supervisors reviewed feedback from videos received via email from the QA center and devised an action plan to address testing errors and deficiencies. There were few instances of invalid tests and few barriers to test completion. Over 97% of KABC-II tests across sites were considered to be valid by the QA center. Overall, the QualiND model was a useful platform for remote supervision to nonspecialist and minimally trained research staff. The QualiND model may be useful to researchers and organizations involved in measuring early child development using standardized tests in low and middle-income countries.

摘要

在撒哈拉以南非洲,婴儿和儿童的神经发育受损(ND)较为普遍。在这些情况下,ND 的标准化测试通常受到限制,因为这些测试需要熟练的人员来进行操作。在本文中,我们提出了一种用于标准化 ND 测试的质量保证(QA)模型(QualiND),讨论了我们在应用 Kaufman 评估儿童第二版(KABC-II)方面的经验得出的发现和影响。QualiND 模型是在 IMPAACT P1104s 研究中实施的,该研究是一项多地点、前瞻性研究,包括 615 名受 HIV 影响的儿童。在 2014 年至 2016 年期间,QualiND 在 6 个位于 4 个非洲国家的地点管理了 18 名测试人员,他们使用 9 种当地语言应用 KABC-II。QualiND 是一个多层次的、视频辅助的迭代模型,整合了远程评估、反馈和监督角色。使用专门的评分标准,经验丰富的工作人员对测试应用的视频进行评估,这些视频是在中央 QA 中心进行评估的。在每个研究地点,测试人员和主管人员都会查看通过电子邮件从 QA 中心收到的反馈视频,并制定行动计划,以解决测试错误和不足。无效测试的情况很少,完成测试的障碍也很少。在各个地点,超过 97%的 KABC-II 测试都被 QA 中心认为是有效的。总体而言,QualiND 模型是对非专业和训练有素的研究人员进行远程监督的有用平台。对于使用标准化测试来衡量中低收入国家儿童早期发育的研究人员和组织来说,QualiND 模型可能是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd7/6375801/85dda31fed59/nihms-989985-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd7/6375801/85dda31fed59/nihms-989985-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcd7/6375801/85dda31fed59/nihms-989985-f0001.jpg